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In this issue of Immunity, Crouse et al., (2014) and Xu et al., (2014), show that bymodulating the expression of
natural killer (NK) cell receptor ligands, type I interferons protect responding T cells against culling by NK
cells.During the early stages of many infec-
tions, a burst of cytokine production is
induced that mobilizes the host response.
This wave of activation typically includes
the synthesis of type I interferons (IFNs),
which instigate an antiviral state that
dampens pathogen replication. Type I
IFNs also have broader actions including
the activation of natural killer (NK) cells
and the amplification of cell-mediated
immunity. NK cells operate to steer
T cell responses by regulating antigen
presentation, producing modulating cyto-
kines such as interleukin-10 (IL-10), and
directly killing host immune cells (Crome
et al., 2013). In addition to triggering NK
cell activation, type I IFN serves as a third
signal, which promotes effector T cell dif-
ferentiation during many viral infections
(Cox et al., 2013).
Several reports have documented that
the removal ofNKcells results in increases
in the size and functionality of CD8+ T cell
responses. During lymphocytic choriome-
ningitis virus (LCMV) infections, depletion
of NK cells preserves the functional CD8+
T cell response and reduces viral loads
(Waggoner et al., 2012; Lang et al., 2012;
Cook and Whitmire, 2013; Waggoner
et al., 2014). NK cells have been shown
to indirectly curtail CD8+ T cell responses
by mediating the perforin-dependent cull-
ing of CD4+ T cells, thereby depriving anti-
viral CD8+ T cells of the helper functions
necessary to support their differentiation
and maintenance (Waggoner et al.,
2012). It has also been documented that
NK cells can directly kill CD8+ T cells
(Crome et al., 2013). Importantly, some
level of antiviral CD8+ T cell response is
usually detectable, even in the presence
of activated NK cells. Why do NK cells
stifle, but not completely ablate, the anti-
viral T cell response, and what are theprotective mechanisms that shield acti-
vated T cells from NK cell attack?
Two reports in this issue of Immunity
(Crouse et al., 2014; Xu et al., 2014)
deconstruct the coupling between type I
IFN signaling and the NK-cell-mediated
containment of antiviral T cells. These
companion studies used microarray anal-
ysis to determine the differential gene-
expression profiles of CD8+ T cells in the
presence or absence of type I IFN
signaling. Xu et al. observed that in vitro
activation of CD8+ T cells in the presence
of type I IFN resulted in increased expres-
sion of classical and nonclassical MHC
molecules, which might render the re-
sponding cells resistant to NK-cell-
mediated attack. Crouse and colleagues
inspected the expression profiles of
wild-type (WT) and type I IFN receptor-
deficient (Ifnar1/) CD8+ T cells following
priming with a vaccinia virus and LCMV
coinfection system. In this case, genes
associated with NK activatory ligands
were expressed at higher amounts in the
absence of type I IFN signaling. Both
series of findings demonstrated that anti-
genic activation of CD8+ T cells coupled
with type I IFN signals alters the balance
of expression of potentially activatory
and inhibitory NK cell ligands. Previous
studies have shown that CD8+ T cells
that do not perceive type I IFN signals
fail to accumulate during certain infec-
tions (Cox et al., 2013); however, Xu
et al. demonstrate that isolated Ifnar1/
CD8+ T cells do expand in vitro, support-
ing the notion that a cell-extrinsic mecha-
nism accounts for the abortive response
in vivo. Collectively, these findings raised
the intriguing possibility that, early during
the course of infection, type I IFN signals
render the responding antiviral CD8+
T cells resistant to culling by NK cells.ImmunityTo test whether type I IFN signaling
saves newly activated antiviral T cells
from attack by NK cells, both groups
tracked the fate of WT and Ifnar1/
CD8+ T cells. The usually weak responses
of Ifnar1/ CD8+ T cells following infec-
tion were rescued if they were primed in
mice lacking or depleted of functional
NK cells. In perforin-deficient recipients,
the magnitude of the response of
Ifnar1/ CD8+ T cells was also restored
to the degree of their WT counterparts,
implying that the NK-cell-mediated lysis
of the antiviral T cells is perforin-depen-
dent, which was confirmed in a series of
killing assays. Similarly, virus-specific
CD4+ T cells are also subject to surveil-
lance by NK cells and are targeted if
they do not receive a type I IFN licensing
signal. Importantly, NK cells appear to
target antigen-activated T cells and not
harm bystander lymphocytes. Thus,
type I IFN acts directly on the responding
T cells early during infection to protect
them from attack by NK cells (Fig-
ure 1). Although the absence of NK
cells circumvents the depletion of acti-
vated Ifnar1/ T cells, quantitative and
qualitative alterations are detected at
later time points, illustrating additional
roles of type I IFN in driving T cell
differentiation.
The sensitivity to NK-cell-mediated
lysis is determined by a fine balance
between the expression of ligands for
NK cell inhibitory and activatory receptors
by the candidate target cell (Crome et al.,
2013). Crouse et al. discovered that
Ifnar1/ virus-specific T cells express
higher amounts of the putative NCR1
ligand and blocking NCR1 (NKp46), an
activating receptor expressed by NK
cells, reduced killing. The use of recipi-
ents with impaired NCR1 expression40, June 19, 2014 ª2014 Elsevier Inc. 861
Figure 1. Type I IFN Signaling Protects Activated T Cells from NK-Cell-Mediated Death
Type I IFN signals to antigen-activated T cells reduce the expression of NK cell activatory ligands and el-
evates the levels of inhibitory ligands, rendering the responding T cell resistant to NK cell attack. Without
type I IFN signals, activated T cells can be targeted by perforin-dependent NK cell killing.
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Previewsfurther confirmed the requirement of this
activatory receptor for T cell culling. NK
cells can react to target cells that are
missing self MHC class I molecules and
type I IFN regulates the expression of
these complexes. Xu et al. demonstrated
that type I IFN causes activated CD8+
T cells to upregulate several MHC class I
molecules, including Qa-1b, a nonclas-
sical class I molecule that serves as the
ligand for the CD94-NKG2A NK cell inhib-
itory receptor. Taken together, these find-
ings imply that type I IFN increases
the amounts of protective MHC mole-
cules and reduces expression of activa-862 Immunity 40, June 19, 2014 ª2014 Elsevtory NK cell ligands by the responding
T cells, reducing their likelihood of being
targeted by NK cells.
These new articles now establish a link
between type I IFN signaling and the
resistance of activated T cells to depletion
by NK cells. This possibly serves as a
mechanism for the removal of T cells
that have become activated in the
absence of type I IFN, providing a check-
point to halt possibly misprimed or auto-
immune responses. This strategy also en-
sures that the responding T cells are
available to fully participate if the type I
IFN warning sign is detected. Althoughier Inc.both studies offer exciting clues regarding
the panels of activatory and inhibitory in-
teractions that determine the life or death
of the T cell, the precise interactions and
ligands that direct this decision remain
unidentified. Moreover, although type I
IFN can license the responding T cells,
whether other infection-associated sig-
nals, such as IL-12 or IL-33, similarly func-
tion to confer resistance to NK cell killing
is also not yet defined. One of the most
impressive aspects of T cell responses is
their tremendous phenotypic diversity. It
will be intriguing to discover whether
type I IFN similarly protects all T cells
from attack or whether a particular subset
of activated cells receive preferential
treatment, are selected to survive, and
go on to dictate the immunological
outcome of the response.REFERENCES
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